These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 688611)

  • 41. Measurement of free-circulating cis-dichlorodiammineplatinum(II) in plasma.
    Bannister SJ; Sternson LA; Repta AJ; James GW
    Clin Chem; 1977 Dec; 23(12):2258-62. PubMed ID: 923077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electrospun polyethylene terephthalate/graphene oxide nanofibrous membrane followed by HPLC for the separation and determination of tamoxifen in human blood plasma.
    Sereshti H; Bakhtiari S; Najarzadekan H; Samadi S
    J Sep Sci; 2017 Sep; 40(17):3383-3391. PubMed ID: 28664592
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determination of 2-methyl derivatives of tamoxifen in cell culture medium using high-performance liquid chromatography and electrochemical detection.
    Chamart S; Hanocq M; Helson M; Devleeschauwer N; Leclercq G
    J Chromatogr; 1989 Nov; 496(2):365-75. PubMed ID: 2613840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The steady-state pharmacokinetics of tamoxifen and its metabolites in breast cancer patients.
    Soininen K; Kleimola T; Elomaa I; Salmo M; Rissanen P
    J Int Med Res; 1986; 14(3):162-5. PubMed ID: 3522312
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sensitive HPLC-PDA determination of tamoxifen and its metabolites N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in human plasma.
    Antunes MV; Rosa DD; Viana Tdos S; Andreolla H; Fontanive TO; Linden R
    J Pharm Biomed Anal; 2013 Mar; 76():13-20. PubMed ID: 23291438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sensitive and selective liquid chromatographic postcolumn reaction detection system for biotin and biocytin using a homogeneous fluorophore-linked assay.
    Przyjazny A; Hentz NG; Bachas LG
    J Chromatogr A; 1993 Nov; 654(1):79-86. PubMed ID: 8275179
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dose-adjustment study of tamoxifen based on CYP2D6 genotypes in Japanese breast cancer patients.
    Kiyotani K; Mushiroda T; Imamura CK; Tanigawara Y; Hosono N; Kubo M; Sasa M; Nakamura Y; Zembutsu H
    Breast Cancer Res Treat; 2012 Jan; 131(1):137-45. PubMed ID: 21947681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liquid chromatography-mass spectrometry method for the quantification of tamoxifen and its metabolite 4-hydroxytamoxifen in rat plasma: application to interaction study with biochanin A (an isoflavone).
    Singh SP; Wahajuddin ; Ali MM; Kohli K; Jain GK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Oct; 879(27):2845-51. PubMed ID: 21890435
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and validation of an UPLC-MS/MS method for the quantification of tamoxifen and its main metabolites in human scalp hair.
    Drooger JC; Jager A; Lam MH; den Boer MD; Sleijfer S; Mathijssen RH; de Bruijn P
    J Pharm Biomed Anal; 2015 Oct; 114():416-25. PubMed ID: 26119504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical pharmacology of tamoxifen in patients with breast cancer: correlation with clinical data.
    Fabian C; Sternson L; El-Serafi M; Cain L; Hearne E
    Cancer; 1981 Aug; 48(4):876-82. PubMed ID: 7272932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Highly sensitive simultaneous quantification of estrogenic tamoxifen metabolites and steroid hormones by LC-MS/MS.
    Johänning J; Heinkele G; Precht JC; Brauch H; Eichelbaum M; Schwab M; Schroth W; Mürdter TE
    Anal Bioanal Chem; 2015 Sep; 407(24):7497-502. PubMed ID: 26206706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic drug monitoring of tamoxifen using LC-MS/MS.
    Tchu SM; Lynch KL; Wu AH
    Methods Mol Biol; 2012; 902():211-22. PubMed ID: 22767121
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A prospective case series of women with estrogen receptor-positive breast cancer: levels of tamoxifen metabolites in controlled ovarian stimulation with high-dose tamoxifen.
    Balkenende EM; Dahhan T; Linn SC; Jager NG; Beijnen JH; Goddijn M
    Hum Reprod; 2013 Apr; 28(4):953-9. PubMed ID: 23335608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An UPLC-MS/MS method for separation and accurate quantification of tamoxifen and its metabolites isomers.
    Arellano C; Allal B; Goubaa A; Roché H; Chatelut E
    J Pharm Biomed Anal; 2014 Nov; 100():254-261. PubMed ID: 25173109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients.
    Romero-Lorca A; Novillo A; Gaibar M; Bandrés F; Fernández-Santander A
    PLoS One; 2015; 10(7):e0132269. PubMed ID: 26176234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. UPLC-MS/MS method for the determination of tobacco-specific biomarker NNAL, tamoxifen and its main metabolites in rat plasma.
    Xiong W; Zhao J; Wang L; Jiang X
    Biomed Chromatogr; 2017 Jun; 31(6):. PubMed ID: 27862094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent.
    Jordan VC; Fritz NF; Langan-Fahey S; Thompson M; Tormey DC
    J Natl Cancer Inst; 1991 Oct; 83(20):1488-91. PubMed ID: 1920495
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determination of bupropion using liquid chromatography with fluorescence detection in pharmaceutical preparations, human plasma and human urine.
    Ulu ST; Tuncel M
    J Chromatogr Sci; 2012 May; 50(5):433-9. PubMed ID: 22454390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancer.
    Langan-Fahey SM; Tormey DC; Jordan VC
    Eur J Cancer; 1990; 26(8):883-8. PubMed ID: 2145931
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bioanalytical high-throughput selected reaction monitoring-LC/MS determination of selected estrogen receptor modulators in human plasma: 2000 samples/day.
    Zweigenbaum J; Henion J
    Anal Chem; 2000 Jun; 72(11):2446-54. PubMed ID: 10857619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.